Gene ontology annotations for HLA-B |
|
Experiment description of studies that identified HLA-B in exosomes |
1 |
Experiment ID |
11 |
MISEV standards |
✘
|
Biophysical techniques |
✔
HSC70|HSP90|MHCII|CD63|CD81
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry [MALDI TOF]
|
PubMed ID |
12519789
|
Organism |
Homo sapiens |
Experiment description |
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. |
Authors |
"Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W" |
Journal name |
JBC
|
Publication year |
2003 |
Sample |
B cells |
Sample name |
RN (HLA-DR15+) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Mass spectrometry [MALDI TOF] Mass spectrometry [QTOF] Western blotting Thin layer chromatography HPLC |
|
|
2 |
Experiment ID |
79 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD81|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 1 |
Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
3 |
Experiment ID |
80 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD81|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis -Sample 2 |
Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
4 |
Experiment ID |
81 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD81|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 3 |
Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
5 |
Experiment ID |
76 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|GAPDH|HSP90|CD81|CD9|CD63|LAMP1|MHCI
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry Western blotting
|
PubMed ID |
20224111
|
Organism |
Homo sapiens |
Experiment description |
Proteomics analysis of bladder cancer exosomes. |
Authors |
"Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A." |
Journal name |
MCP
|
Publication year |
2010 |
Sample |
Bladder cancer cells |
Sample name |
HT1376 |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.10-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF/TOF] Western blotting FACS |
|
|
6 |
Experiment ID |
497 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
7 |
Experiment ID |
498 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
8 |
Experiment ID |
21 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
Alix|TSG101|HSP70|CD63
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
19837982
|
Organism |
Homo sapiens |
Experiment description |
Proteomic and bioinformatic analysis of immunoaffinity-purified exosomes derived from the human colon tumor cell line LIM1215. |
Authors |
"Suresh Mathivanan, Justin W.E. Lim, Bow J. Tauro, Hong Ji, Robert L. Moritz and Richard J. Simpson" |
Journal name |
MCP
|
Publication year |
2009 |
Sample |
Colorectal cancer cells |
Sample name |
LIM1215 |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.10-1.12 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [Orbitrap] Western blotting |
|
|
9 |
Experiment ID |
1203 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
SDCBP|FLOT1|CD9|CD81|CD63|EPCAM|GAPDH|LAMP1|TFRC|CD151|CD82|LAMP2|RAB35|TSG101|FLOT2|RAB5B|ICAM1|RAB5A
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
34887515
|
Organism |
Homo sapiens |
Experiment description |
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets |
Authors |
"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ." |
Journal name |
Nat Cell Biol
|
Publication year |
2021 |
Sample |
Colorectal cancer cells |
Sample name |
DiFi |
Isolation/purification methods |
Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation OptiPrep density gradient centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein miRNA |
Methods used in the study |
Western blotting Mass spectrometry RNA sequencing |
|
|
10 |
Experiment ID |
363 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
11 |
Experiment ID |
363 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
12 |
Experiment ID |
364 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
13 |
Experiment ID |
364 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
14 |
Experiment ID |
365 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
15 |
Experiment ID |
365 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
16 |
Experiment ID |
254 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1|CD81
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
MNT-1 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
17 |
Experiment ID |
255 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
G1 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
18 |
Experiment ID |
256 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
501mel |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
19 |
Experiment ID |
257 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
Daju |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
20 |
Experiment ID |
259 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
A375M |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
21 |
Experiment ID |
260 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1|CD81
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
1205Lu |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
22 |
Experiment ID |
488 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Homo sapiens |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Mesenchymal stem cells |
Sample name |
UCMSC |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
23 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
24 |
Experiment ID |
231 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD63|CD9
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
25 |
Experiment ID |
232 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
26 |
Experiment ID |
233 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
27 |
Experiment ID |
141 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
VCaP - Rep 3 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
28 |
Experiment ID |
66 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19199708
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
Journal name |
JPR
|
Publication year |
2009 |
Sample |
Saliva |
Sample name |
Saliva |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
29 |
Experiment ID |
217 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
30 |
Experiment ID |
63 |
MISEV standards |
✘
|
Biophysical techniques |
✔
AQP2
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19056867
|
Organism |
Homo sapiens |
Experiment description |
Large-scale proteomics and phosphoproteomics of urinary exosomes. |
Authors |
"Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA" |
Journal name |
JASN
|
Publication year |
2009 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
Protein-protein interactions for HLA-B |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
UBE2H |
7328 |
Affinity Capture-MS |
|
Homo sapiens |
|
2 |
INTS4 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
3 |
DOPEY2 |
9980 |
Affinity Capture-MS |
|
Homo sapiens |
|
4 |
RHOF |
54509 |
Affinity Capture-MS |
|
Homo sapiens |
|
5 |
MON2 |
23041 |
Affinity Capture-MS |
|
Homo sapiens |
|
6 |
ATR |
|
Affinity Capture-MS |
|
Homo sapiens |
|
7 |
PCK1 |
5105 |
Affinity Capture-MS |
|
Homo sapiens |
|
8 |
CHRNA4 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
9 |
C1orf27 |
54953 |
Affinity Capture-MS |
|
Homo sapiens |
|
10 |
HLA-E |
3133 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
11 |
NUP188 |
23511 |
Affinity Capture-MS |
|
Homo sapiens |
|
12 |
ABCC1 |
4363 |
Affinity Capture-MS |
|
Homo sapiens |
|
13 |
ADRB2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
14 |
PAICS |
10606 |
Affinity Capture-MS |
|
Homo sapiens |
|
15 |
TUBB8 |
347688 |
Affinity Capture-MS |
|
Homo sapiens |
|
16 |
ATP12A |
479 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
17 |
SPNS1 |
83985 |
Affinity Capture-MS |
|
Homo sapiens |
|
18 |
SLC27A6 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
19 |
INTS1 |
26173 |
Affinity Capture-MS |
|
Homo sapiens |
|
20 |
VPS51 |
738 |
Affinity Capture-MS |
|
Homo sapiens |
|
21 |
LTN1 |
26046 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
22 |
GCN1L1 |
10985 |
Affinity Capture-MS |
|
Homo sapiens |
|
23 |
C1orf112 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
24 |
PI4KA |
5297 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
25 |
SLC39A3 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
26 |
SLC5A6 |
8884 |
Affinity Capture-MS |
|
Homo sapiens |
|
27 |
TELO2 |
9894 |
Affinity Capture-MS |
|
Homo sapiens |
|
28 |
INTS8 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
29 |
ADAM21 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
30 |
SLC38A5 |
92745 |
Affinity Capture-MS |
|
Homo sapiens |
|
31 |
RUVBL1 |
8607 |
Affinity Capture-MS |
|
Homo sapiens |
|
32 |
TRIM28 |
10155 |
Affinity Capture-MS |
|
Homo sapiens |
|
33 |
B3GNT2 |
10678 |
Affinity Capture-MS |
|
Homo sapiens |
|
34 |
LPGAT1 |
9926 |
Affinity Capture-MS |
|
Homo sapiens |
|
35 |
KIF23 |
9493 |
Affinity Capture-MS |
|
Homo sapiens |
|
36 |
VARS |
7407 |
Affinity Capture-MS |
|
Homo sapiens |
|
37 |
MDN1 |
23195 |
Affinity Capture-MS |
|
Homo sapiens |
|
38 |
HLA-B |
3106 |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
39 |
SMPD4 |
55627 |
Affinity Capture-MS |
|
Homo sapiens |
|
40 |
RHBDD2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
41 |
LILRB1 |
|
Reconstituted Complex |
|
Homo sapiens |
|
42 |
ERAP1 |
51752 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
43 |
KLRC1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
44 |
AHCY |
191 |
Affinity Capture-MS |
|
Homo sapiens |
|
45 |
FANCD2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
46 |
DNAJC16 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
47 |
TNFSF9 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
48 |
WDFY3 |
23001 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
49 |
UFSP2 |
55325 |
Affinity Capture-MS |
|
Homo sapiens |
|
50 |
PRKDC |
5591 |
Affinity Capture-MS |
|
Homo sapiens |
|
51 |
BTAF1 |
9044 |
Affinity Capture-MS |
|
Homo sapiens |
|
52 |
ACSL1 |
2180 |
Affinity Capture-MS |
|
Homo sapiens |
|
53 |
RAB35 |
11021 |
Affinity Capture-MS |
|
Homo sapiens |
|
54 |
ARFGEF2 |
10564 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
55 |
| | |